Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Any time we try a healthy new way of eating, it’s easy for doubt to creep in. Is it really working? Is it worth it? Does it ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

Ivim takes a comprehensive approach to obesity care and its customized patient-centric plans are carefully overseen by ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, are considered GLP-1 drugs ... or 15 mg per 0.5 mL doses in a single-dose pen.

the active ingredient in the GLP-1 drugs Mounjaro and Zepbound, were removed from the drug shortage list. The OFA’s suit argues that the supply of Ozempic and Wegovy cannot meet current demand ...

Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, are considered GLP-1 drugs. Lilly reported earlier ... or 15 mg per 0.5 mL doses in a ...